Wells Fargo’s GT Biopharma GTBP Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$6.54K Hold
16,037
﹤0.01% 6056
2025
Q4
$12.6K Buy
16,037
+6,025
+60% +$4.28K ﹤0.01% 5901
2025
Q3
$5.87K Hold
10,012
﹤0.01% 6048
2025
Q2
$35.8K Sell
10,012
-1
-0% -$3 ﹤0.01% 5619
2025
Q1
$21.5K Hold
10,013
﹤0.01% 5685
2024
Q4
$30.5K Hold
10,013
﹤0.01% 5637
2024
Q3
$23.1K Hold
10,013
﹤0.01% 5605
2024
Q2
$28.3K Sell
10,013
-11
-0.1% -$39 ﹤0.01% 5487
2024
Q1
$44.4K Hold
10,024
﹤0.01% 5305
2023
Q4
$76.7K Buy
10,024
+1
+0% +$7 ﹤0.01% 5069
2023
Q3
$72.5K Buy
10,023
+6,670
+199% +$55.1K ﹤0.01% 4965
2023
Q2
$31.4K Buy
3,353
+1
+0% +$10 ﹤0.01% 5607
2023
Q1
$55.3K Hold
3,352
﹤0.01% 5115
2022
Q4
$89.1K Buy
3,352
+3,334
+18,522% +$167K ﹤0.01% 4595
2022
Q3
$1K Sell
18
-2
-10% -$153 ﹤0.01% 6351
2022
Q2
$2K Sell
20
-988
-98% -$74.9K ﹤0.01% 6322
2022
Q1
$87K Buy
1,008
+653
+184% +$57.6K ﹤0.01% 5395
2021
Q4
$32K Buy
355
+296
+502% +$44.3K ﹤0.01% 6167
2021
Q3
$13K Buy
59
+46
+354% +$13.8K ﹤0.01% 6112
2021
Q2
$6K Buy
13
+9
+225% +$3.74K ﹤0.01% 6282
2021
Q1
$1K Buy
+4
New +$699 ﹤0.01% 6719

Other funds holding GTBP